The non-stress test (NST) monitors fetal heart rate and movements to assess fetal well‑being and oxygenation. During the test, accelerations with fetal movement are expected; absence or recurrent decelerations may indicate fetal distress or compromised placental function. It’s commonly used in late pregnancy or high‑risk pregnancies to detect problems and guide further testing or management, including possible delivery.

A normal NST is a reactive tracing: at least two fetal heart‑rate accelerations within 20 minutes. For pregnancies ≥32 weeks, accelerations are ≥15 bpm lasting ≥15 seconds; before 32 weeks, ≥10 bpm for ≥10 seconds. Baseline fetal heart rate is normally 110–160 bpm with moderate variability. A reactive NST generally indicates fetal well‑being; a nonreactive result may need further evaluation.

An NST can be nonreactive (often called “failed”) due to fetal sleep cycles, prematurity, maternal medications (beta‑blockers, opioids), poor tracing from maternal obesity or movement, placental or uteroplacental insufficiency, fetal hypoxia or acidemia, congenital cardiac issues or arrhythmias, and maternal smoking or chronic conditions like diabetes or hypertension. Nonreactive results prompt further testing (biophysical profile or contraction stress test).

No, an NST is generally not painful. It’s a noninvasive fetal monitoring test where two belts and sensors are placed on the abdomen to record the baby’s heart rate and movements; you may feel mild pressure or discomfort from the straps or from lying still for 20–40 minutes. Rarely, skin irritation or anxiety from fetal activity occurs. Tell your provider if concerned.

No, a non‑stress test (NST) is not compulsory for all pregnancies. It’s a noninvasive monitoring tool recommended when concerns arise—reduced fetal movements, high‑risk conditions like diabetes or preeclampsia, post‑term pregnancy, or suspected growth problems. Clinicians decide case-by-case; NSTs are commonly used and considered safe to assess fetal well‑being. If recommended, follow-up testing or increased surveillance may be advised.

A non-stress test (NST) is done to assess fetal well‑being by monitoring the baby’s heart rate in response to fetal movements. It evaluates oxygenation and autonomic function to detect signs of fetal distress, hypoxia or uteroplacental insufficiency. NSTs are used when there are decreased fetal movements, high‑risk conditions (e.g., maternal diabetes, hypertension, post-term, growth restriction) or prior pregnancy complications.